SCHEMBL1287680

SCHEMBL1287680

CCCCOCc1ccco1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
MAPT P10636 6/20 0.47
POLB P06746 4/20 0.47
HPGD P15428 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
GAA P10253 1/20 0.46
CYP2D6 P10635 2/20 0.43
USP2 O75604 1/20 0.43
MAPK1 P28482 1/20 0.43
TSHR P16473 2/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 2/20 0.40
TP53 P04637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4613994 0.95 ALDH1A1 (0.46) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL5935759 0.93 ALDH1A1 (0.45) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL28829849 0.93 ALDH1A1 (0.45) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL10626417 0.93 ALDH1A1 (0.45) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL21227107 0.93 ALDH1A1 (0.45) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL10385356 0.93 ALDH1A1 (0.45) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL10423917 0.93 ALDH1A1 (0.45) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL10942355 0.89 ALDH1A1 (0.50) ALDH1A1MAPTPOLBHPGDSMN1; SMN2
SCHEMBL8206271 0.86 ALDH1A1 (0.47) ALDH1A1MAPTPOLBHPGDGAA
SCHEMBL20324518 0.85 ALDH1A1 (0.47) ALDH1A1MAPTPOLBHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119018907-A Preparation method and application of modified molecular sieve 中国科学院宁波材料技术与工程研究所 2024-11-26 CN claimed
EP-2989094-A1 CATALYTIC SYNTHESIS OF REDUCED FURAN DERIVATIVES Archer Daniels Midland Company (US) 2016-03-02 EP claimed
US-20160052902-A1 CATALYTIC SYNTHESIS OF REDUCED FURAN DERIVATIVES ARCHER DANIELS MIDLAND CO (US) 2016-02-25 US claimed
CN-105143211-A Catalytic synthesis of reduced furan derivatives ARCHER DANIELS MIDLAND CO 2015-12-09 CN claimed
WO-2014175989-A1 CATALYTIC SYNTHESIS OF REDUCED FURAN DERIVATIVES ARCHER DANIELS MIDLAND COMPANY (US) 2014-10-30 WO claimed
WO-2014149281-A1 LAYER-BY-LAYER DEPOSITION OF CARBON-DOPED OXIDE FILMS APPLIED MATERIALS, INC. (US) 2014-09-25 WO claimed
US-12325687-B2 Process for the conversion of furfuryl alcohol into a levulinate ester GFBIOCHEMICALS IP ASSETS B.V. (NL) 2025-06-10 US disclosed
EP-4196460-B1 A PROCESS FOR THE CONVERSION OF FURFURYL ALCOHOL INTO A LEVULINATE ESTER GFBIOCHEMICALS IP ASSETS B V (NL) 2025-05-07 EP disclosed
CN-119018907-A Preparation method and application of modified molecular sieve 中国科学院宁波材料技术与工程研究所 2024-11-26 CN disclosed
CN-119018907-A Preparation method and application of modified molecular sieve 中国科学院宁波材料技术与工程研究所 2024-11-26 CN disclosed
CN-116351416-B Non-noble metal catalyst for preparing furfurether by etherification of furfuraldehyde, and preparation method and use method thereof 郑州大学 2024-08-13 CN disclosed
CN-118302403-A Process for forming alkyl esters of levulinic acid 巴斯夫欧洲公司 2024-07-05 CN disclosed
CN-117524848-A High density low Wen Tanmo for hard mask and other patterning applications 应用材料公司 2024-02-06 CN disclosed
WO-2008094792-A1 NOVEL AIR GAP INTEGRATION SCHEME APPLIED MATERIALS, INC. (US) 2008-08-07 WO disclosed
EP-1599898-A2 METHOD TO IMPROVE CRACKING THRESHOLDS AND MECHANICAL PROPERTIES OF LOW-K DIELECTRIC MATERIAL Applied Materials, Inc. (US) 2005-11-30 EP disclosed
EP-1588410-A1 A METHOD OF IMPROVING STABILITY IN LOW K BARRIER LAYERS Applied Materials, Inc. (US) 2005-10-26 EP disclosed
WO-2005087974-A2 CVD PROCESSES FOR THE DEPOSITION OF AMORPHOUS CARBON FILMS APPLIED MATERIALS, INC. (US) 2005-09-22 WO disclosed
WO-2004064136-A1 A METHOD OF IMPROVING STABILITY IN LOW K BARRIER LAYERS APPLIED MATERIALS, INC. (US) 2004-07-29 WO disclosed
WO-2004063417-A2 METHOD TO IMPROVE CRACKING THRESHOLDS AND MECHANICAL PROPERTIES OF LOW-K DIELECTRIC MATERIAL APPLIED MATERIALS, INC. (US) 2004-07-29 WO disclosed
US-4496767-A REARRANGEMENT, ESTERIFICATION AND REDUCTION OF A FURAN-CARBINOL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160052902-A1 CATALYTIC SYNTHESIS OF REDUCED FURAN DERIVATIVES ADH5, FASN, ADH1C ALDH1A1 45/4885MAPT 4719/4885POLB 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.